OUR COMPANIES
MindFrame
MindFrame was acquired by Covidien (NYSE: COV) in 2012. MindFrame was an early-stage company developing a novel mechanical device for the treatment of acute ischemic stroke.
MindFrame was acquired by Covidien (NYSE: COV) in 2012. MindFrame was an early-stage company developing a novel mechanical device for the treatment of acute ischemic stroke.